Scott Burbank, MD
Orthopaedic Surgery · Pineville, NCNPI 1154537751
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (47.9%), travel and lodging and food and beverage — rather than concentrated in one kind of arrangement. Smith+Nephew accounts for 65.4% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $7,304, more than ten times the $53 reported in 2019.
Across 46 payments — averaging $231.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Smith+Nephew$7K
- Johnson & Johnson$2K
- Peerless Surgical Inc.$1K
- Medacta USA, Inc.$240
- Dynasplint Systems Inc.$115
- Avanos Medical$76
- plus $275 from 8 others
What the payments were for
- Consulting fees$5,10048%
- Travel & lodging$2,74226%
- Food & beverage$1,55815%
- Education$1,24912%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Smith+Nephew | 10 | $6,963 |
| Johnson & Johnson(2 entities) | 10 | $1,659 |
| Peerless Surgical Inc. | 4 | $1,321 |
| Medacta USA, Inc. | 3 | $240 |
| Dynasplint Systems Inc. | 2 | $115 |
| Avanos Medical | 4 | $76 |
| Vertex | 2 | $57 |
| ERMI LLC | 2 | $50 |
| Medical Device Business Services, Inc. | 2 | $38 |
| Bioventus LLC | 2 | $37 |
| Stryker | 2 | $34 |
| Polynovo North America LLC | 1 | $24 |
| Amgen | 1 | $19 |
| Pacira Pharmaceuticals Incorporated | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,648 in reported general payments places this provider in the 65th percentile of 845 orthopaedic surgery providers in North Carolina.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 113 | $1,111 |
| Celecoxib | 18 | $564 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 24 | $290 |
| Methylprednisolone | 45 | $232 |
| Meloxicam | 63 | $225 |
| Cyclobenzaprine Hcl | 37 | $178 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $166 |
| Gabapentin | 12 | $122 |
| Tramadol Hcl | 43 | $60 |
| Amoxicillin | 25 | $40 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic surgery in Pineville
- Thomas FehringCharlotte$18.3M
- Walter BeaverCharlotte$7.4M
- Robert AndersonCharlotte$6.6M
- William JiranekDurham$6.4M
- John MasonCharlotte$5.7M
- Thomas VailDurham$5.7M
- William DavisCharlotte$5.2M
- John EllingtonCharlotte$4.9M
- Mark EasleyDurham$4M
- Carroll JonesCharlotte$3.6M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.